Screener
International Flavors & Fragrances IFF Health & Biosciences — Restructuring Charges
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by International Flavors & Fragrances in its filing.
Tagged under the XBRL concept us-gaap:RestructuringCharges.
The source filing: International Flavors & Fragrances’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:24 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000051253-26-000017
FAQ
- What is International Flavors & Fragrances's health & biosciences — restructuring charges?
- International Flavors & Fragrances (IFF) reported health & biosciences — restructuring charges of $2M in Q1 2026.
- How has International Flavors & Fragrances's health & biosciences — restructuring charges changed year-over-year?
- International Flavors & Fragrances's health & biosciences — restructuring charges decreased by 33.3% year-over-year, from $3M to $2M.
- What does health & biosciences — restructuring charges mean?
- Represents non-recurring costs associated with reorganizing, downsizing, or streamlining operations within the Health & Biosciences segment. These charges often include severance, facility closures, and asset write-downs intended to improve long-term operational efficiency.
Ask your AI about International Flavors & Fragrances's health & biosciences — restructuring charges.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude